meta_analysis
    2021
    High Quality

    The effects of astaxanthin supplementation on obesity, blood pressure, CRP, glycemic biomarkers, and lipid profile: a meta-analysis of randomized controlled trials

    Ursoniu S, Sahebkar A, Serban MC, Banach M

    Published in Pharmacological Research

    Key Findings

    Astaxanthin did not significantly change body weight, BMI, blood pressure, CRP, fasting glucose, HbA1c, LDL or HDL across pooled randomized trials.

    Conclusions

    Astaxanthin has no consistent effect on cardiometabolic risk markers despite antioxidant activity.

    Limitations

    Pooled trials small and short; doses varied widely; possible under-powering for subgroups.

    Supplements Studied

    Astaxanthin
    Compound

    Astaxanthin did not significantly change body weight, BMI, blood pressure, CRP, fasting glucose, HbA1c, LDL or HDL across pooled randomized trials.

    Outcomes Measured

    Cholesterol Management

    Astaxanthin did not significantly change LDL or HDL cholesterol across pooled randomized trials.

    Blood Sugar Balance

    Astaxanthin did not significantly change fasting glucose or HbA1c in pooled randomized trials.

    Related Health Concerns

    Obesity

    Study Details

    Year:2021
    Sample Size:638
    Duration:12 weeks
    Quality Score:8/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.